Lexaria says some DehydraTECH formulas hit its best absorption yet and filed 3 patents. Semaglutide brain levels were too low to measure in this rat study.
Recap by typeshit. Full story at Investing News Network.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
NPR counted about 2,000 pancreatitis cases among the suits, per a Facebook share of its reporting. The post is brief, so the fuller breakdown is at the source.
The Prestige cites NPR's review of 190,000 GLP-1 adverse event filings since 2024, which counted about 2,000 pancreatitis cases and 1,000 reports of sudden blindness.
Loading…